71 results
Page 3 of 4
8-K
EX-99.1
sic5pkwbllgqqnh6c
8 Jul 19
Other Events
7:16am
8-K
EX-99.1
xjal hreuqra49fs
8 May 19
Aravive Reports First Quarter 2019 Financial Results and Provides Recent Corporate Updates
4:15pm
8-K
EX-99.1
0zta4psk0xhl6fgz pk
7 Mar 19
Results of Operations and Financial Condition
4:16pm
8-K
EX-10.2
3yw aoo2zj
12 Feb 19
Departure of Directors or Certain Officers
4:20pm
8-K
EX-10.4
603r46b ln
12 Feb 19
Departure of Directors or Certain Officers
4:20pm
8-K
EX-99.1
vuuyaa
5 Feb 19
Regulation FD Disclosure
7:01am
8-K
EX-99.1
opfavecfw
11 Dec 18
Other Events
9:00am
8-K
EX-99.1
ev2 pfgthjvdo6
13 Nov 18
Aravive Presents Detailed Results of Phase 1 Clinical Trial of AVB-S6-500 at the 2018 EORTC-NCI-AACR Symposium
7:10am
8-K
EX-99.1
k3vcysm
6 Nov 18
Aravive Reports Third Quarter 2018 Financial Results and Provides Company Updates
4:20pm
8-K
EX-99.1
9w0txyopci5uetmc2ts
30 Oct 18
Regulation FD Disclosure
6:16am
S-8
EX-4.10
238 fjqygxsxde
17 Oct 18
Registration of securities for employees
12:00am
S-8
EX-4.9
3aohsglg deyk9i0
17 Oct 18
Registration of securities for employees
12:00am
8-K/A
ngt1wn8vsj apa
8 Aug 18
Versartis Reports Second Quarter 2018 Financial Results and Reviews Recent Developments
4:09pm
8-K/A
EX-99.1
vse9sg
8 Aug 18
Versartis Reports Second Quarter 2018 Financial Results and Reviews Recent Developments
4:09pm
425
4hf9m
8 Aug 18
Business combination disclosure
4:07pm
425
EX-99.1
l1i9b 0xe87ru1
8 Aug 18
Business combination disclosure
4:07pm
8-K
EX-99.1
3dar6
7 Aug 18
Versartis Reports Second Quarter 2018 Financial Results and Reviews Recent Developments
12:00am
S-4
EX-10.1
wshpza7l 2m
3 Aug 18
Registration of securities issued in business combination transactions
5:26pm